• SENSEX 81,306.85
    -693.86 (--0.85%)
  • BANKNIFTY 55,149.40
    -606.05 (--1.09%)
  • N S D L
    1,307.00 1,425.00(%)
  • Apollo Micro Sys
    240.60 240.60(%)
  • Vodafone Idea
    7.29 16.55(%)
  • Netweb Technol.
    2,361.20 3,060.00(%)
  • Ola Electric
    46.90 39.58(%)
  • GOCL Corpn.
    401.00 517.00(%)
  • R Systems Intl.
    496.95 557.80(%)
  • Bharat Forge
    1,120.45 919.10(%)
  • Hind.Aeronautics
    4,462.05 3,045.95(%)
  • Oswal Agro Mills
    83.00 110.69(%)
  • Aditya Bir. Fas.
    81.95 132.82(%)
  • Royal Orch.Hotel
    495.55 495.55(%)
  • M & M
    3,419.70 3,430.00(%)
  • ITC
    397.50 391.50(%)
  • Suzlon Energy
    59.28 86.04(%)
  • Reliance Industr
    1,408.00 1,115.55(%)
  • One 97
    1,277.95 1,277.95(%)
  • HDFC Bank
    1,957.60 1,613.40(%)
  • DCX Systems
    285.80 393.00(%)
  • Tata Motors
    678.50 542.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Akums Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 34484.0
  • ISIN : INE09XN01023
480.05 -2 (-0.36%)
  • As on 23 Aug 2025 (EOD)

  • Today’s Low

    476.15

  • Today’s High

    486.00

  • Open

    481.80

  • Perv Close

    481.80

  • 52W Low

    405.00

  • 52W High

    1,008.95

Key Indicators

  • P/E(TTM)

    46.12

  • Mar.Cap (₹Cr.)

    7,555.70

  • Div & Yield %

    0.00

  • Book Value(₹)

    146.52

  • Debt-Equity Ratio

    -0.36

  • AGM Date

    22-Aug-2025

  • EPS

    10.42

  • P/E Ratio

    46.12

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    7,555.70

  • RONW (%)

    -2.22

  • ROCE (%)

    1.24

Score Board

  • Equity (₹ in Cr.)

    31.48

  • BV (₹)

    146.50

  • Sales( ₹ in Cr.)

    1,311.78

  • NP (in Cr.)

    161.04

  • NP Var(%)

    202.0

  • Div%

    0.0

  • CPS (₹)

    12.70

  • EPS (₹)

    10.20

  • Traded Value (₹ in Lakhs)

    7,563.57

  • 52 Week High

    1,008.95

  • 52 Week Low

    405.00

  • Price BSE

    481.0

  • Price NSE

    480.00

  • Market Capital( in Cr.)

    7,563.57

  • P/C Ratio

    37.70

  • P/E Ratio

    47.00

  • Price Vs.BV

    10.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,311.78 1,444.12 1,286.83 1,162.06 837.44 736.91
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,311.78 1,444.12 1,286.83 1,162.06 837.44 736.91
Other Income 128.06 94.12 96.15 58.48 54.51 65.52
Stock Adjustments 10.05 -6.44 3.06 18.45 -10.64 -8.52
Total Income 1,449.89 1,531.80 1,386.04 1,238.99 881.31 793.91
EXPENDITURE :            
Raw Materials 811.06 867.24 791.21 786.51 513.05 457.83
Power and Fuel Cost 45.36 42.40 42.04 36.25 28.64 33.74
Employee Cost 201.74 175.28 147.30 136.37 122.65 123.70
Other Manufacturing Expenses 68.18 62.69 42.04 62.62 51.89 24.08
Selling and Administration Expenses 23.27 31.90 22.33 16.82 13.80 12.05
Miscellaneous Expenses 37.60 404.21 147.63 503.99 319.56 37.06
Employee Benefit Expenses 201.74 175.28 147.30 136.37 122.65 123.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,187.20 1,583.73 1,192.54 1,542.55 1,049.59 688.46
Operating Profit 262.69 -51.93 193.50 -303.56 -168.28 105.45
Interest 15.31 18.31 13.18 3.65 0.82 4.34
Gross Profit 247.38 -70.24 180.32 -307.21 -169.10 101.11
Depreciation 39.55 32.69 30.00 27.76 26.10 25.26
Profit Before Tax 207.83 -102.93 150.32 -334.97 -195.20 75.85
Current Tax 46.84 62.52 41.00 0.34 6.40 23.61
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 -16.11 46.46 -56.17 1.38
Reported Net Profit 161.00 -165.45 125.43 -381.78 -145.43 50.86
Extraordinary Items -0.04 -7.98 -105.11 0.99 -255.75 0.02
Adjusted Net Profit 161.04 -157.47 230.54 -382.77 110.32 50.84
Adjustment below Net Profit 861.44 -2.18 0.00 -11.62 0.16 0.00
P & L Balance brought forward 295.39 463.02 351.36 744.75 890.02 839.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 13.77 0.00 0.00 0.37
P & L Balance carried down 1,317.83 295.39 463.02 351.36 744.75 890.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 10.52 -11.56 8.77 -53.37 -1,117.82 391.04
Earnings Per Share(Adj)-Unit Curr 10.52 - - - - -
Book Value 150.57 10.06 21.77 25.94 4,358.55 5,476.91
Book Value(Adj)-Unit Curr 150.57 - - - - -

Shareholding Pattern

  • Promoter Group

    75.26%

  • Public Share Holding

    22.01%

  • Custodian

    2.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,255,480 34.47 54,255,480 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 64,200,000 40.79 64,200,000 1
Others 0 0.00 0 0
Sub Total 118,455,480 75.26 118,455,480 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6,667,788 4.24 6,667,788 55
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 956,256 0.61 956,256 6
Mutual Funds / UTI 10,591,442 6.73 10,591,442 18
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,382,686 1.51 2,382,686 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,598,172 13.09 20,598,172 85
2] Non Institution
Bodies Corporate 567,075 0.36 567,075 219
Clearing Members 54 0.00 54 1
Directors of their Relatives 42 0.00 42 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 127,328 0.08 127,328 454
Foreign Non Institution Other 7,278,535 4.62 7,278,535 1
Hindu Undivided Families 316,836 0.20 316,836 1,614
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 129,000 0.08 129,000 1
Individuals holding nominal share capital up to Rs. 1 lakh 5,541,026 3.52 5,541,026 67,013
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 6,956 0.00 6,956 3
Others 794 0.00 794 2
Sub Total 14,048,406 8.93 14,048,406 69,333
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 4,291,930 2.73 4,291,930 1
Total Shares held by Custodians and against which Depository Receipts have been issued 4,291,930 2.73 4,291,930 1
Grand Total ( A + B + C ) 157,393,988 100.00 157,393,988 69,424

Company Background

Akums Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Akums Drugs & Pharmaceuticals Ltd
  • BSE Code : 34484.0
  • ISIN : INE09XN01023

  • Incorporation Year

    2004

  • Registered Office

    304 Mohan Place LSC Saraswati
    Vihar, Delhi,
    Delhi-110034

  • Telephone

    +91 11 6904 1000

  • FAX

  • Chairman

  • Managing Director

    SANDEEP JAIN

  • Company Secretary

    Dharamvir Malik

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Akums Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Akums Drugs 480.55 1,439.84 1,311.78 46.12 10.70
Abbott India 31,909.75 6,684.73 6,409.15 46.69 44.95
Astrazeneca Phar 8,431.65 1,756.92 1,716.29 114.97 32.94
P & G Health Ltd 6,573.80 944.52 934.17 36.30 40.23
Glaxosmi. Pharma 2,799.50 3,866.05 3,723.49 50.34 58.72
Cipla 1,592.30 20,029.57 19,044.85 23.80 21.40
Amrutanjan Healt 701.35 437.58 421.23 37.19 20.84
Guj. Themis Bio. 399.70 152.47 150.80 97.73 27.21
Fermenta Biotec. 336.10 442.21 430.53 11.15 17.61
Bliss GVS Pharma 161.45 703.42 667.20 24.13 9.16
Ambalal Sarabhai 34.33 19.33 4.04 17.97 2.10